Lai, Kar Neng
Tang, Sydney C. W.
Schena, Francesco Paolo
Novak, Jan
Tomino, Yasuhiko
Fogo, Agnes B.
Glassock, Richard J.
Article History
First Online: 11 February 2016
Competing interests
: S.C.W.T. is the recipient of the ‘Yu Professorship in Nephrology’ at the University of Hong Kong. F.P.S. has been supported by the grant QLG-1CT-2000-00464 from the European Framework Programme and the Schena Foundation, Bari, Italy. J.N. reports his current funding from the NIH, Bethesda, Maryland, USA, a gift from the IgA Nephropathy Foundation of America, and sponsored-research agreements with Pfizer and Anthera. J.N. is also a co-inventor on the US patent application 14/318,082 (assigned to UAB Research Foundation), and is a co-founder of Reliant Glycosciences, LLC. R.J.G. is a consultant for Abbvie, Astellas, Bristol-Myers Squibb, Chemocentryx, Eli Lilly, Mitsubishi, Sanofi-Genzyme, Wolters-Kluwer (UpToDate), Karger (<i>American Journal of Nephrology and Karger Blog</i>) and American Society of Nephrology (NephSAP). R.J.G. holds stock ownership in REATA, Inc. All other authors declare no competing interests.